D
David Bergqvist
Researcher at Uppsala University
Publications - 120
Citations - 14437
David Bergqvist is an academic researcher from Uppsala University. The author has contributed to research in topics: Low molecular weight heparin & Heparin. The author has an hindex of 40, co-authored 120 publications receiving 13694 citations. Previous affiliations of David Bergqvist include Uppsala University Hospital & Lund University.
Papers
More filters
Journal ArticleDOI
Prevention of Venous Thromboembolism* American College of Chest Physicians Evidence- Based Clinical Practice Guidelines (8th Edition)
William H. Geerts,David Bergqvist,Graham F. Pineo,John A. Heit,Charles M. Samama,Michael R. Lassen,Clifford W. Colwell +6 more
TL;DR: This article discusses the prevention of venous thromboembolism (VTE) and is part of the Antithrombotic and Thrombolytic Therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Journal ArticleDOI
Prevention of Venous Thromboembolism : The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
William H. Geerts,Graham F. Pineo,John A. Heit,David Bergqvist,Michael R. Lassen,Clifford W. Colwell,Joel G. Ray +6 more
TL;DR: This article discusses the prevention of venous thromboembolism (VTE) and is part of the Seventh American College of Chest Physicians Conference on Antithrombotic and Thrombolytic Therapy: Evidence-Based Guidelines.
Journal ArticleDOI
Venous thromboembolism (VTE) in Europe - The number of VTE events and associated morbidity and mortality
Alexander T. Cohen,Giancarlo Agnelli,Frederick A. Anderson,Juan I. Arcelus,David Bergqvist,Josef G. Brecht,Ian A. Greer,John A. Heit,Julia L. Hutchinson,Ajay K. Kakkar,Dominique Mottier,Emmanuel Oger,Meyer Michel Samama,Michael Spannagl +13 more
TL;DR: The estimated total number of symptomatic VTE events (range based on probabilistic sensitivity analysis) per annum within the six EU countries was 465,715; almost three-quarters of all VTE-related deaths were from hospital-acquired VTE.
Journal ArticleDOI
Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer.
David Bergqvist,Giancarlo Agnelli,Alexander T. Cohen,Amiram Eldor,Paul E. Nilsson,A Le Moigne-Amrani,F Dietrich-Neto +6 more
TL;DR: Enoxaparin prophylaxis for four weeks after surgery for abdominal or pelvic cancer is safe and significantly reduces the incidence of venographically demonstrated thrombosis, as compared with enoxapin prophyllaxis for one week.
Journal ArticleDOI
Ruptured abdominal aortic aneurysm: A population-based study
Henrik Bengtsson,David Bergqvist +1 more
TL;DR: The incidence of aneurysm rupture in the city of Malmö, Sweden from 1971 to 1986 was not low compared with other Scandinavian studies, but was low in comparison with studies from the United Kingdom.